Discovery of 2-(4-Ureido-piperidin-1-yl)-4-morpholinothieno [3,2-D] Pyrimidines as Orally Bioavailable Phosphoinositide-3-Kinase Inhibitors with In Vitro and In Vivo Antitumor Efficacy in Triple-Negative Breast Cancer
用户6X7Ch8WUQ_gI
3小时前
11
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-10-13 21:28:26 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规